Ipsen is an international specialty pharmaceutical group. Our expertise in steroid, peptide & protein engineering enables us to explore & develop new approaches in the treatment of endocrinology, oncology & neuromuscular disorders among others. Ipsen invests over 20% of sales in Research & Development and has a commercial presence in over 30 countries